ClinConnect ClinConnect Logo
Search / Trial NCT02312362

High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP

Launched by OERTLI INSTRUMENTE AG · Dec 5, 2014

Trial Information

Current as of July 25, 2025

Unknown status

Keywords

Hfds Ab Interno Migs Surgery

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients suffering from primary open-angle glaucoma (POAG) inadequately controlled with maximum tolerated medical therapy and who will be treated with cataract surgery.
  • Exclusion Criteria:
  • One eyed patients
  • Unwilling or unable to give consent, unwilling to accept randomization, or unable to return for scheduled protocol visits
  • The presence of extreme narrow angle with complete or partial closure in either eye, except for occludable angles treated with a patent iridectomy
  • Any abnormality preventing reliable applanation tonometry, any opacity or patient uncooperativeness that would restrict adequate examination of the ocular fundus or anterior chamber of either eye
  • The risk of visual field or visual acuity worsening as a consequence of participation in the trial, in the investigator's opinion
  • Any clinically significant, serious, or severe medical or psychiatric condition; any condition that, in the investigator's opinion, would interfere with optimal participation in the study or present a special risk to the patient
  • Participation in any other investigational study within 30 days prior to baseline visit

About Oertli Instrumente Ag

Oertli Instrumente AG is a leading Swiss medical technology company specializing in the development and manufacturing of innovative surgical instruments and devices for ophthalmology. With a commitment to enhancing patient care and improving surgical outcomes, Oertli combines cutting-edge technology with a deep understanding of clinical needs. The company emphasizes quality and precision in its products, which are designed to support ophthalmic surgeons in performing complex procedures with efficiency and safety. Through rigorous research and development, Oertli Instrumente AG actively contributes to advancing the field of ophthalmic surgery, ensuring that healthcare professionals have access to reliable and effective tools.

Locations

Kiel, , Germany

Mumbai, , India

Geneva, , Switzerland

Aswan, , Egypt

Reinach, , Switzerland

Patients applied

0 patients applied

Trial Officials

Farhad Hafezi, MD, PhD

Principal Investigator

University of Geneva, Switzerland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials